Bone tissue engineering is an emerging field providing viable substitutes for bone regeneration. Recent advances have allowed scientists and engineers to develop scaffolds for guided bone growth. However, success requires scaffolds to have specific macroscopic geometries and internal architectures conducive to biological and biophysical functions. Freeform fabrication provides an effective process tool to manufacture three-dimensional porous scaffolds with complex shapes and designed properties. A novel precision extruding deposition (PED) technique was developed to fabricate polycaprolactone (PCL) scaffolds. It was possible to manufacture scaffolds with a controlled pore size of 350 μm with designed structural orientations using this method. The scaffold morphology, internal micro-architecture and mechanical properties were evaluated using scanning electron microscopy (SEM), micro-computed tomography (micro-CT) and mechanical testing, respectively. An in vitro cell-scaffold interaction study was carried out using primary fetal bovine osteoblasts. Specifically, the cell proliferation and differentiation was evaluated by Alamar Blue assay for cell metabolic activity, alkaline phosphatase activity and osteoblast production of calcium. An in vivo study was performed on nude mice to determine the capability of osteoblast-seeded PCL to induce osteogenesis. Each scaffold was implanted subcutaneously in nude mice and, following sacrifice, was explanted at one of a series of time intervals. The explants were then evaluated histologically for possible areas of osseointegration. Microscopy and radiological examination showed multiple areas of osseous ingrowth suggesting that the osteoblast-seeded PCL scaffolds evoke osteogenesis in vivo. These studies demonstrated the viability of the PED process to fabricate PCL scaffolds having the necessary mechanical properties, structural integrity, and controlled pore size and interconnectivity desired for bone tissue engineering.
Introduction
Three-dimensional scaffolds play important roles in scaffoldguided tissue engineering. They provide initial support as an artificial extracellular matrix necessary for cell attachment, 3 Author to whom any correspondence should be addressed. proliferation and migration before the cells can differentiate into viable tissue. The design, fabrication and characterization of tissue engineering scaffolds are challenging tasks in regenerative medicine, particularly, for load-bearing tissues such as bone and cartilage. It is necessary, however, to develop a method to fabricate three-dimensional cell-specific surfaces that are capable of reproducing the properties of native extracellular bone matrix. To design this type of bone tissue scaffold one may need to address multiple biological, mechanical and geometric design constraints in terms of scaffold external and internal geometry, porosity, pore size and interconnectivity. Scaffolds should provide structural integrity, strength, transport properties such as permeability and an ideal micro-environment for cell and tissue ingrowth and healing (Hutmacher 2000 , Hollister et al 2002 , Sun and Lal 2002 . For example, the effect of implant pore size on bone regeneration has been illuminated by experiments demonstrating an optimum pore size range of 100-350 μm (Whang et al 1999 , Hutmacher 2001 . Ensuring adequate mechanical performance under loads is another critical bone scaffold requirement where if the scaffold cannot provide a mechanical modulus in the range of hard tissue (10-1500 MPa) then any nascent tissue formation will probably also fail due to excessive deformation (Hollister 2005) . Advances in computer-aided tissue engineering and the implementation of biomimetic design approaches have allowed scientists to introduce these and other biological and biophysical requirements into the scaffold design (Sun et al 2004a (Sun et al , 2004b . However, such scaffolds often have intricate architectures that can only be fabricated through advanced manufacturing techniques. Most available scaffold fabrication methods such as solvent casting, fiber bonding, phase separation, gas-induced foaming and salt leaching are either limited to producing scaffolds with simple geometries or depend on indirect casting methods for scaffold fabrication (Hollister et al 2002, Sun and Lal 2002) . There is a practical need for developing novel methods to fabricate scaffolds with complex architectures. Solid freeform fabrication techniques, such as 3D printing, multi-phase jet solidification, selective laser sintering and fused deposition modeling (FDM) have been widely adopted for scaffold fabrication to address this need (Wu et al 1996 , Koch et al 1998 , Zein et al 2002 , Xiong et al 2001 , Vozzi et al 2002 , Williams et al 2005 , Rohner et al 2003 , Chim et al 2006 . Among the reported techniques, FDM-based extruding deposition is an ideal method because of its versatility in using different scaffolding materials, possibility of manufacturing scaffolds in a cell-friendly environment and feasibility of controlled dropon-demand high precision deposition (Williams et al 2005 , Rohner et al 2003 , Chim et al 2006 .
In addition to the design, mechanical and biological characterization methods play an important role in the fabrication of effective scaffolds.
The biological and mechanical function of the scaffold depends on its microarchitecture.
Micro-computed tomographic (micro-CT) imaging technology enables the characterization of the salient features of the scaffolds for tissue engineering applications. Recent reports have shown that micro-CT techniques are capable of characterizing micro-architectural and mechanical properties of tissue scaffolds (Williams et al 2005 , Rohner et al 2003 , Chim et al 2006 , Lin et al 2003 , Müller and Rüegsegger 1997 . Furthermore, micro-CT can be used to evaluate porous biomaterials as well as quantify the bone tissue morphologies and internal stress-strain behavior (Rohner et al 2003 , Müller and Rüegsegger 1997 , Cancedda et al 2007 , Ho and Hutmacher 2006 , Oest et al 2007 . Micro-CT possesses an added advantage over other techniques with its inherent ability for nondestructive evaluation of tissue properties (Cancedda et al 2007) .
In this paper, the feasibility of precision extruding deposition (PED) to fabricate poly--caprolactone (PCL) tissue engineering scaffolds with designed micro-architectures was evaluated. Successful fabrication of PCL scaffolds using FDM and selective laser sintering (SLS) techniques has been demonstrated (Williams et al 2005 , Rohner et al 2003 , Chim et al 2006 . In contrast to the conventional FDM process that requires the use of pre-cursor filaments, the PED process that is presented herein directly extrudes scaffolding materials in a granulated form, thereby avoiding the need for filament preparation. The process can deposit the extruded material according to the designed micro-scale features allowing the manufacture of scaffolds with complex architectures. Scanning electron microscopy (SEM) and micro-CT were implemented to characterize the morphology and internal microstructures of the PED-fabricated scaffolds, respectively. An Instron 5800R mechanical testing device was used to assess the mechanical performance of the porous scaffolds. The cell-scaffold interaction in vitro was studied using primary fetal bovine osteoblasts. The in vivo study was carried out using a nude-mouse model to investigate the osteogenic properties of PED-fabricated PCL scaffolds. The constructs were implanted subcutaneously, and the animals were sacrificed at pre-set time points. Following sacrifice, the scaffolds were explanted and examined both radiologically and histologically.
Materials and methods

Scaffold fabrication
PCL (Sigma Aldrich Inc., Milwaukee, Wisconsin) in the form of pellets was used as the scaffold material. It has a low glass transition temperature of −60
• C, a melting temperature of approximately 58-60
• C and a high thermal stability. It has a high decomposition temperature of 350
• C. A PED system developed at Drexel University was used for scaffold fabrication (Bellini 2002) . The hardware component consists of an XYZ position system, a material extruder system and a temperature control system. The software component consists of data processing software and system control software. The data processing software slices the STL files and generates the process toolpath. The system control software directs the material deposition according to the process toolpath to form a layered 3D object. The mini-extruder system delivers the PCL in a molten form through the deposition nozzle. The pelletform PCL is then melted by a liquefier temperature provided by two heating bands and thermal couples. The PCL is finally extruded due to pressure created by a rotating precision screw. The PED system is shown in (figure 1).
To achieve deposition accuracy, the positioning system and the material mini-extruder were synchronized. The material deposition roads (of both contouring and raster filing) consist of a series of line segments, so the extruder movement is composed of a series of 2D linear interpolations upon which a simultaneous proportional signal to the XY position is extracted. The signal is used to drive the rotating motor of the material extruder. The proportional ratio can be adjusted to coordinate the positioning system and material dispensing system according to its controlled movement, speed and material extrusion flow rate. The designed scaffold computer-aided design (CAD) model was first converted into stereolithography (STL) format, and then sliced using a slice pattern stored in the pattern library for toolpath generation. Each layer was then filled with the designed-scaffold pattern to generate a toolpath file. The strands of PCL were extruded with a layer pattern of a 0
• /90 • orientation to create the porous structure. The in-house developed system control software provided the functions for 3D part visualization, machine and process setup, testing and real-time monitoring during the fabrication process.
Morphological SEM study
An FEI/Philips XL-30 field emission environmental scanning electron microscope was used to evaluate the micro-structural form and internal morphology of the PED-fabricated scaffolds. These SEM images were taken by using a beam intensity of 20 kV and gaseous secondary electron detectors set at 1.3 Torr.
Microstructure analysis and 3D reconstruction by micro-CT
A SkyScan (Kontich, Belgium) 1172 micro-CT desktop scanner was used to scan the internal architecture of the scaffold. The micro-CT was set at 19.1 μm resolution. The output format for each sample was approximately 500 serial 1024 × 1024 bitmap images. These sliced images were analyzed in SkyScan's CTAN software. Volume fraction and surface per unit volume were determined using 3D analysis. Three-dimensional reconstruction was performed using Mimics software (Materialise, Leuven, Belgium). Sixty two sequential pixel images were cropped from the serial images from the center of each sample. These serial core images were reconstructed into 3D volumetric models after importing them into Mimics.
Mechanical properties of scaffolds
An Instron 5800R machine was used to evaluate the compressive properties of PED-fabricated scaffolds with dimensions of 14 mm × 14 mm × 3 mm. The samples were sandwiched between compression plates tested at a speed of 0.1 mm min −1 . The initial strain rate was adjusted to 10% per minute, without any load before initiating compression testing. Standard solid compression platens were used for testing. Stress-strain data were computed from load-displacement measurements. The compressive modulus was determined based on the slope of the stress-strain curve in the elastic region, and the compressive strength was reported at 10% strain. The data were corrected on the strain axis to a value of approximately 0.025 for measuring the compressive modulus of the scaffold. For comparative purposes, non-porous bulk samples of the overall equivalent dimension were fabricated using the PED system and evaluated in the same manner.
In vitro evaluation of cell-scaffold interaction
Scaffolds of dimensions 14 mm × 14 mm × 3 mm, porosity of 65% and pore sizes of approximately 350 μm were seeded with primary fetal bovine osteoblast cells for a period of 21 days. The initial medium to support cell proliferation was prepared by mixing 1 L of distilled H 2 O, 13.5 gm of DMEM powder mix (Sigma, St. Louis, MO), 0.0059 gm ascorbic Acid (Sigma, St. Louis, MO), 0.0588 gm gentamicin (Sigma, St. Louis, MO), 3.7 gm sodium bicarbonate (Sigma, St. Louis, MO), 3.905 gm HEPES buffer (Sigma, St. Louis, MO) and 20 mL antibiotic/antimycotic solution (Sigma, St. Louis, MO). The medium was then filtered through a 0.22 μm filter into 500 mL sterile bottles, and 88 mL of FBS (Sigma, St. Louis, MO) and 0.71 mL of 100X ITS (Sigma, St. Louis, MO) per 500 mL medium were then added. For mineralization, 0.0783 gm calcium chloride (Sigma, St. Louis, MO) and 2.54 gm beta-glycerol phosphate (Sigma, St. Louis, MO) supplements were added before filtering. The scaffolds were submerged in 70% ethanol for sterilization and allowed to dry overnight. They were then washed with phosphate buffered saline (PBS) and soaked in 2 mL of a medium for 1 h. Approximately 1.5 × 10 6 cells were seeded onto each scaffold. The cell scaffold constructs were maintained in culture for 21 days.
2.5.1.
Cell viability. Alamar Blue assay (Invitrogen, Carlsbad, CA), a fluorometric indicator of cell metabolic activity, was performed to determine cell viability. The cellscaffold constructs were removed from the culture plates on days 3, 7, 11, 14 and 21. They were washed with PBS after aspirating the medium after which 1.8 mL of media and 0.2 mL of the Alamar Blue dye were added to allow for a 4 h incubation period. The resulting 2 mL solution was removed from the sample, and the fluorescence was measured at room temperature on a plate reader (GENios, TECAN, Durham, NC) using excitation and emission wavelengths of 520 nm and 590 nm, respectively.
Alkaline phosphatase activity.
Samples were removed from the medium and washed twice with a phosphate buffer solution (PBS) on days 7, 14 and 21. The scaffolds were then submerged into 1 mL of 1% Triton X-100 solution (Sigma, St. Louis, MO) for cell lysis. They were then centrifuged and the supernatant was used to calculate alkaline phosphatase (ALP) activity by the p-nitro phenyl phosphate (p-NPP) method (Sigma, St. Louis, MO). Alkaline phosphatase catalyzes the cleavage of p-NPP to give p-nitrophenol and orthophosphate which exhibits a yellow color. A 0.5 mL sample of supernatant and 0.5 mL of diluted p-NPP (100 μL of p-NPP concentrate per 2 mL of 100 mM sodium bicarbonate/carbonate buffer, pH 10) were mixed and incubated for 45 min. The absorbance of this mixture was read at 405 nm. The absorbance was converted to the units of alkaline phosphatase L −1 .
Calcium production.
Calcium levels were measured in the cell-scaffold constructs with a calcium test kit (Stanbio Laboratories, Boerne, TX). The manufacturer's protocols were followed on days 7, 14 and 21. The assay is based on the o-cresolphthalin complexone method which develops a purple color in the presence of calcium. The cell lysate was prepared using 0.5 mL Triton X-100 and 0.5 mL trichloroacetic acid. The samples were incubated for 60 min and centrifuged. The supernatant was used to calculate the calcium levels. 0.01 mL of supernatant, 0.5 mL color reagent (o-cresolphthalin complexone) and 0.5 mL base reagent (2-amino, 2-methyl, 1-propanol) were mixed and incubated for 10 min. The absorbance was read at 550 nm with the amount of calcium production calculated from the standard curve.
2.5.4.
Cell morphology by SEM. The cell-scaffold constructs were removed from the culture media on days 14 and 21. They were washed twice with 1× PBS and then fixed with 4% glutaraldehyde for 2 h. The constructs were then subjected to serial dilutions of ethanol (20%, 50%, 70%, 90%, 100%), with each step exposure of 10 min for dehydration. The constructs were then refrigerated overnight at 4
• C. The scaffolds were then coated with platinum and observed under SEM.
In vivo osteogenesis study
The review and investigation of the in vivo osteogenesis study protocol and the research specified by the protocol was conducted at the Department of Orthopaedic Surgery at The Medical University of South Carolina. Fetal bovine osteoblast cells (5 × 10 6 cells/implant) were cultured, mixed homogeneously in media, and seeded directly using a Pasteur pipet onto the external top surface of the PCL scaffolds fabricated at a pore size specification of approximately 200 μm.
The environment for pre-implantation cell attachment included incubation in culture media at 37
• C and 5% CO 2 . The samples of 2.5 × 8 mm cell-scaffold specimens were implanted into the subcutaneous tissue of 5-week-old nude mice. An in vivo osteogenesis study was carried out on 12 animals with one scaffold implanted per animal. Four animals per study period were sacrificed at 4, 6 and 8 weeks postoperatively. Specifically, four implants were explanted for each study period (i.e., four at week 4, four at week 8 and four at week 12). After each study period, implants were removed and micro-CT scanning performed. The explants were fixed in 10% formalin for 1 day. They were then dehydrated in a series of ethanol dilutions (70%, 95% and 100%), exposed to xylene and embedded in paraffin. 5 μm thick sections were made and stained with haematoxylin and eosin (H&E) staining solution. Each section was evaluated histologically and with micro-CT scanning to identify areas of osseous ingrowth.
Statistical analysis
The statistical significance was determined by pairwise t-test at the significance level of less than 0.05 (p < 0.05) using the SPSS 14 for Windows R software package.
Results
Morphological evaluation by SEM
The SEM images of the scaffolds are shown in figures 2(A) and (B) along with the image of the as-fabricated scaffold in figure 2(C). The gaps, struts and internal pore connectivity, as observed under SEM, demonstrate use of the PED process to fabricate PCL scaffolds at the micro-scale level. The SEM images clearly demonstrate that the PED-fabricated microarchitecture of the scaffolds via a 0
• /90 • layered pattern can achieve a desired pore size of 200 μm.
Microstructure characterization by micro-CT
Micro-CT enables 3D characterization of PED-fabricated PCL scaffolds. Both 2D and 3D analyses of porous core regions of the sample scaffolds were performed. A 3D reconstructed model using Mimics software is displayed in figure 3 . Three PCL scaffolds modeled using the 3D reconstruction technique were analyzed for their porosity. They were found to be 64.723 ± 0.84% porous with near 100% interconnectivity. These results show little variation between samples, illustrating the repeatability of the process.
Mechanical properties of scaffolds
Three specimens were tested under compression to a limit of specific compressive displacements. These PCL specimens were measured for their dimensions for accurate area calculations. The scaffolds were cylindrically shaped with minute irregularities on the circumference wall due to specimen processing. The average data are plotted (figure 4).
The compressive modulus of scaffolds was found to be 59 MPa with a standard deviation of ±1.3 MPa. The compressive strength of the scaffolds was measured to be 5.3 MPa with a standard deviation of ±0.103 MPa. By comparison, the fabricated non-porous samples had a compressive modulus of 109 MPa with a standard deviation of ±2.3 MPa.
Cell-scaffold interaction study
Alamar Blue assay was performed to determine cell viability with fluorescent indicators of cell metabolic activity. The cells showed increased metabolic activity over time until day 11, thus representing an active proliferation period (figure 5).
The data are presented as the average of the four samples ± standard deviation. There was a statistically significant difference (p < 0.05) in the cell metabolic activity over the cultured time. A slight decline was experienced between days 11 and 14. The decline in cell metabolic activity may be attributed to the cells entering the quiescent G0 phase (the resting phase where the cell has exited the cycle and has temporarily stopped dividing) of the cell cycle after which a new developmental phase resumes. However, further investigation is necessary to validate this hypothesis. To probe aggregate cell function, alkaline phosphatase (ALP) activity was measured at days 7, 14 and 21. An up-regulation of alkaline phosphatase activity throughout the cultured time was observed, with the greatest increase within the first 14 days (figure 6). In interpreting this graph, it is important to note that ALP activity was not normalized to cell number, and therefore increases in ALP activity may be partially attributed to cell number increase as opposed to enhanced cell functional activity alone.
Mineralization or deposition of calcium on the scaffolds was measured by calculating the amount of calcium produced by cells on days 7, 14 and 21. A steady increase in the amount of calcium produced by cells throughout the cultured time was observed (figure 7).
Both ALP and calcium activities were measured from the four samples. Statistically significant differences (P < 0.05) in both the functional activities were observed over the cultured period. The morphology and extent of mineralization on the PCL surfaces were assessed using SEM at the study end point on day 21. The SEM images show that the entire scaffolds were covered by mineralized matrix by day 21 (figure 8).
In vivo osteogenesis study
The calcium deposition indicating osseous ingrowth was seen in the radiographic images ( figure 9(A) ). Bright white areas indicating osteogenesis became apparent first in the 6 week group ( figure 9(B) ).
These areas became more pronounced at the 8 week time period ( figure 9(C) ). The sections of osseous ingrowth are shown histologically using H&E staining on decalcified samples (figure 10).
After using H&E staining procedures, the areas of bone growth could be differentiated from the surrounding tissues. The areas of bone matrix (dark pink) were surrounded by osteocytes (i.e., smaller purple regions surrounding the dark pink masses). These areas became more numerous and pronounced at the 8 week time period. Also, the bone matrix appeared to have become more complete in these sections (figure 11).
Micro-CT was carried out on the constructs explanted after 8 weeks. The image analysis was carried out to visualize the areas of osseous ingrowth. The areas of bone ingrowth into the scaffold are demonstrated (figure 12).
Discussion
Precision extruding deposition freeform fabrication of PCL scaffolds was tested using SEM, micro-CT and biological assays to characterize the morphology, internal geometry, mechanical properties and biological compatibility of these scaffolds. For the fabrication process, the results demonstrated the capability of PED fabrication to manufacture PCL scaffolds with controlled microstructure and strut size features of 345.35 μm ± 5.90 μm, matching those of literature data on in vivo bone (i.e. between 200 um and 400 um). The scaffolds were 65% porous with 100% interconnectivity. Since this process directly fabricated scaffolds using a pore geometry design for layer-by-layer deposition without involving the material preparation and indirect casting, new opportunities for complex scaffold fabrication were created. This paper then reported on three phases of scaffold characterization that test the novel PED fabrication strategy for rendering poly-E-caprolactone (PCL) scaffolds to be used in scaffoldguided bone tissue engineering or 3D tissue formation. The first phase of research in the reported project is the characterization of a PED scaffold rendering accuracy and mechanical properties. The second phase of characterization is the study of scaffold seeding and in vitro scaffold-cell interaction. These scaffolds are then used in the third and final phase of characterization with an in vivo test in a nude mouse model. First, for the mechanical testing of the scaffolds, compression testing results of our mechanical matched well with the in vivo cortical bone value ranges from the literature. Micro-CT characterization was then found to be an effective tool for nondestructive evaluation of PCL scaffolds. The use of 2D analysis and 3D reconstruction software allowed the examination of morphologies, internal architecture, the interconnectivity of as-fabricated tissue scaffolds and provided a quantitative measurement of porosity and micro-architecture. The pore size of scaffolds determined to be between 200 and 400 μm was the optimal size suggested for bone tissue scaffold applications. In addition, strut width was found to be consistent between samples. An in vitro cell-scaffold interaction study demonstrated the biocompatibility of the process and material, and also suggested larger spaces for further investigation and improvement. Alamar Blue assay was implemented as a marker of cellular viability and showed statistically significant difference in the osteoblast cell-seeded scaffold metabolic activity over the cultured time. To assess aggregate cell-seeded scaffold functional activity, alkaline phosphatase and calcium assays demonstrated increasing alkaline phosphatase and calcium deposition, respectively, over the study period. Finally, an in vivo study suggested that there was increased osseous ingrowth during the 8 week study period, indicating that the osteoblast cells were able to attach and proliferate on the PCL scaffold. The homogeneous dark pink areas within the stained slides were assumed to be the pockets of bone matrix formation, due to the noticeable calcium deposits/bone formation seen in the corresponding radiographs. With relation to the micro-CT analysis, the authors have provided qualitative microstructural data and porosity for the scaffolds used in both in vitro and in vivo studies. Therefore, the assertion in the paper that the specimens are filled with bone ingrowth is based strictly on the qualitative images, whereas in the future quantitative data on PED scaffold rendering accuracy and percent of the scaffold volume occupied needs to be investigated. Micro-CT may also be exploited in a future study where micro-CT data can be used to determine how accurately the PED-fabricated porous scaffolds replicate the original scaffold design via an overlay study. Furthermore, the micro-CT sections were produced from a scan of the specimen before it was physically sectioned for histology, but for future study a method should be implemented to correlate the 3D micro-CT images with serial 2D histological images. Future in vivo studies will involve larger animal models, such as rabbit calvarial defect or radial defect models to further study the feasibility of computer-aided precision extruded PCL or other candidate scaffold biomaterials for bone tissue engineering.
Conclusion
The ability to fabricate porous PCL scaffolds using the PED system was demonstrated.
The results of the characterization demonstrated the accuracy and process repeatability of PED fabrication for controlled microstructures and a physiologically relevant pore sizes. Success in scaffoldguided tissue engineering requires a greater understanding of the cellular response to the constructed microenvironment. PED has the advantage of high precision on the micro-scale as well as repeatability not amenable to more traditional scaffold manufacturing methods. This process opens opportunities for complex scaffold fabrication. A cell-scaffold interaction study demonstrated the biocompatibility of the process and material. Success in scaffold-guided tissue engineering requires a good understanding of the cellular response to the constructed microenvironment. With this technique, scaffolds with complex internal geometries can be studied with the ultimate goal of generating structures optimized for bone tissue ingrowth.
